House

• Navi Medical Technologies' Neonav® ECG Tip Location System Receives FDA 510(k) Clearance

  

  Revolutionising Vascular Access Care for Critically Ill Newborns and Children Key Points: FDA 510(k) ClearanceNeonav® ECG Tip Location System is now FDA-cleared,enabling its use in U.S. hospitals

  02-18

  Details

• Five USANA Country/Region Markets Recognized for Product Excellence by Euromonitor International

  

  USANA Malaysia,Philippines,Singapore,Taiwanand Hong Kongregion all awarded KUALA LUMPUR,Malaysia,Feb. 15,2025-- Five of USANA Health Sciences\' Asia Pacific markets were recently awarded by the prest

  02-18

  Details

• Vitafoods India 2025: Angel Yeast Brings Innovative Yeast Protein to Dining Table

  

  MUMBAI,India,Feb. 17,2025-- Angel Yeast (SH600298),a global leader in yeast manufacturing,has recently showcased its revolutionary yeast protein solutions and products at the 2025 Vitafoods India whi

  02-18

  Details

• Pre-order Centauri Carbon Now: Elegoo's First Core-XY 3D Printer for Reliability in Creativity

  

  SHENZHEN,China,Feb. 17,2025-- Elegoo,a rapidly developing brand in global smart manufacturing,officially launches pre-orders today for its first Core-XY 3D printer,built for top reliability to boost

  02-18

  Details

• Axel Klarmeyer Joins Chamlion as CEO, Chamlion International

  

  NANJING,China,Feb. 14,2025-- Chamlion,a pioneer in integrated dental 3D printing solutions,is pleased to announce the appointment of Axel Klarmeyer as the CEO of Chamlion International,overseeing the

  02-17

  Details

• CIMB Singapore Maintains Leading Position On Returns For New Business Accounts Opening

  

  New customers enjoy 3.0%*p.a. on SGD BusinessGo / BusinessGo-i Account and 3.8%* p.a. on USD Interest Plus Current Account / USD BusinessGo-i Account

  02-17

  Details

• LONGi maintains AAA ranking in Q4 2024 PV ModuleTech Bankability Ratings

  

  XI\'AN,China,Feb. 14,2025-- LONGi has announced the retention of its AAA rating in PV-Tech\'s Q4 2024 PV ModuleTech bankability ratings,marking the company\'s 20th consecutive quarter at this top tie

  02-17

  Details

• Bambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases

  

  BOSTON,Feb. 14,2025-- Bambusa Therapeutics,Inc. (Bambusa),a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders,today announced the successfu

  02-17

  Details

• LambdaTest unveils 2024 Partner of the Year Award winners

  

  LambdaTest Partner Awards 2024 honors the top partners globally for their contributions to quality engineering and innovation.

  02-17

  Details

• Appier provides strong FY25 guidance and a sustainable, profitable growth trajectory

  

  Agreement to acquire AdCreative.ai set to improve gross margins,enhance product synergies,and expand total addressable market

  02-17

  Details